Chunling Yan1,2, Yanlin He1, Yuanzhong Xu3, Gang Shu1,4, Chunmei Wang1, Yongjie Yang1, Kenji Saito1, Pingwen Xu1, Antentor Othrell Hinton1, Xiaofeng Yan1, Likai Yu1,5, Qi Wu1, Patrick Tso6, Qingchun Tong3, Yong Xu1,7. 1. Children's Nutrition ReseARHh Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030. 2. Medical College of Qingdao University, Qingdao, China 266020. 3. Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030. 4. Department of Physiology, Institute of Animal Science, Southern China University of Agriculture, Guangzhou, China. 5. Department of Rheumatology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, China. 6. Department of Pathology and Laboratory Medicine, University of Cincinnati, 2120 East Galbraith Road, Cincinnati, OH, 45237. 7. Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030.
Abstract
BACKGROUND/AIMS: Apolipoprotein A-IV (apoA-IV) in the brain potently suppresses food intake. However, the mechanisms underlying its anorexigenic effects remain to be identified. METHODS: We first examined the effects of apoA-IV on cellular activities in hypothalamic neurons that co-express agouti-related peptide (AgRP) and neuropeptide Y (NPY) and in neurons that express pro-opiomelanocortin (POMC). We then compared anorexigenic effects of apoA-IV in wild-type mice and in mutant mice lacking melanocortin 4 receptors (MC4Rs; the receptors of AgRP and the POMC gene product). Finally, we examined expression of apoA-IV in mouse hypothalamus and quantified its protein levels at fed versus fasted states. RESULTS: We demonstrate that apoA-IV inhibited the firing rate of AgRP/NPY neurons. The decreased firing was associated with hyperpolarized membrane potential and decreased miniature excitatory postsynaptic current. We further used c-fos immunoreactivity to show that intracerebroventricular (i.c.v.) injections of apoA-IV abolished the fasting-induced activation of AgRP/NPY neurons in mice. Further, we found that apoA-IV depolarized POMC neurons and increased their firing rate. In addition, genetic deletion of MC4Rs blocked anorexigenic effects of i.c.v. apoA-IV. Finally, we detected endogenous apoA-IV in multiple neural populations in the mouse hypothalamus, including AgRP/NPY neurons, and food deprivation suppressed hypothalamic apoA-IV protein levels. CONCLUSION: Our findings support a model where central apoA-IV inhibits AgRP/NPY neurons and activates POMC neurons to activate MC4Rs, which in turn suppresses food intake.
BACKGROUND/AIMS: Apolipoprotein A-IV (apoA-IV) in the brain potently suppresses food intake. However, the mechanisms underlying its anorexigenic effects remain to be identified. METHODS: We first examined the effects of apoA-IV on cellular activities in hypothalamic neurons that co-express agouti-related peptide (AgRP) and neuropeptide Y (NPY) and in neurons that express pro-opiomelanocortin (POMC). We then compared anorexigenic effects of apoA-IV in wild-type mice and in mutant mice lacking melanocortin 4 receptors (MC4Rs; the receptors of AgRP and the POMC gene product). Finally, we examined expression of apoA-IV in mousehypothalamus and quantified its protein levels at fed versus fasted states. RESULTS: We demonstrate that apoA-IV inhibited the firing rate of AgRP/NPY neurons. The decreased firing was associated with hyperpolarized membrane potential and decreased miniature excitatory postsynaptic current. We further used c-fos immunoreactivity to show that intracerebroventricular (i.c.v.) injections of apoA-IV abolished the fasting-induced activation of AgRP/NPY neurons in mice. Further, we found that apoA-IV depolarized POMC neurons and increased their firing rate. In addition, genetic deletion of MC4Rs blocked anorexigenic effects of i.c.v. apoA-IV. Finally, we detected endogenous apoA-IV in multiple neural populations in the mousehypothalamus, including AgRP/NPY neurons, and food deprivation suppressed hypothalamic apoA-IV protein levels. CONCLUSION: Our findings support a model where central apoA-IV inhibits AgRP/NPY neurons and activates POMC neurons to activate MC4Rs, which in turn suppresses food intake.
Authors: Eric D Berglund; Chen Liu; Jong-Woo Sohn; Tiemin Liu; Mi Hwa Kim; Charlotte E Lee; Claudia R Vianna; Kevin W Williams; Yong Xu; Joel K Elmquist Journal: J Clin Invest Date: 2013-11-01 Impact factor: 14.808
Authors: D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee Journal: Cell Date: 1997-01-10 Impact factor: 41.582
Authors: Yong Xu; Thekkethil P Nedungadi; Liangru Zhu; Nasim Sobhani; Boman G Irani; Kathryn E Davis; Xiaorui Zhang; Fang Zou; Lana M Gent; Lisa D Hahner; Sohaib A Khan; Carol F Elias; Joel K Elmquist; Deborah J Clegg Journal: Cell Metab Date: 2011-10-05 Impact factor: 27.287
Authors: Linda Madisen; Theresa A Zwingman; Susan M Sunkin; Seung Wook Oh; Hatim A Zariwala; Hong Gu; Lydia L Ng; Richard D Palmiter; Michael J Hawrylycz; Allan R Jones; Ed S Lein; Hongkui Zeng Journal: Nat Neurosci Date: 2009-12-20 Impact factor: 24.884
Authors: Qi Zhu; Jonathan Weng; Minqian Shen; Jace Fish; Zhujun Shen; Karen T Coschigano; W Sean Davidson; Patrick Tso; Haifei Shi; Chunmin C Lo Journal: Endocrinology Date: 2020-04-01 Impact factor: 4.736
Authors: Na Kyung Lee; Sang Eon Park; Soo Jin Kwon; Sangmi Shim; Yeji Byeon; Jong-Hwa Kim; Duk L Na; Jong Wook Chang Journal: Sci Rep Date: 2017-01-04 Impact factor: 4.379
Authors: Eivind Larssen; Cato Brede; Anne Hjelle; Anne Bolette Tjensvoll; Katrine Brække Norheim; Kjetil Bårdsen; Kristin Jonsdottir; Peter Ruoff; Roald Omdal; Mari Mæland Nilsen Journal: SAGE Open Med Date: 2019-05-13
Authors: Sydney Pence; Zachary LaRussa; Zhijun Shen; Min Liu; Karen T Coschigano; Haifei Shi; Chunmin C Lo Journal: Int J Mol Sci Date: 2021-01-27 Impact factor: 5.923
Authors: Magdalena Wit; Jonathan Trujillo-Viera; Akim Strohmeyer; Martin Klingenspor; Mohammed Hankir; Grzegorz Sumara Journal: EMBO Mol Med Date: 2022-04-19 Impact factor: 14.260
Authors: Clemens Duerrschmid; Yanlin He; Chunmei Wang; Chia Li; Juan C Bournat; Chase Romere; Pradip K Saha; Mark E Lee; Kevin J Phillips; Mahim Jain; Peilin Jia; Zhongming Zhao; Monica Farias; Qi Wu; Dianna M Milewicz; V Reid Sutton; David D Moore; Nancy F Butte; Michael J Krashes; Yong Xu; Atul R Chopra Journal: Nat Med Date: 2017-11-06 Impact factor: 53.440